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Results of a Screening Program for Multiple Endocrine Neoplasia Type 
2A: A Clinical Study of a Japanese Family 
Takashi Shimotake,* Naomi Iwai,* Jun Yanagihara,* Tetsuro Kobayashi,* 
and Shin-ichiro Takai 
A Japanese family of 87 members in five generations wilh mulliple endocrine neoplasia type 2A (MEN 
2A) is described regarding the utility of screening tests for early detection of medullary thyroid 
carcinoma andthe potential for DNA diagnosis of MEN 2 A gene carriers. The screening pro grams for 
family members in this series include measurements of plasma calcitonin concentrations after 
intravenous injection of pentagastrin (0.5 \i.glkgl5 sec) and 24-hour urinary excretion of 
catecholamines. While 18 MEN 2A patients had been previously diagnosed, these screening programs 
revealed five addilional patients with MEN 2A (aged 16, 19, 35, 37. and 57). Prediction of MEN 2A 
gene carriers by DNA analysis has been attempted bul is not yet possible in this family. (Henry Ford 
Ho.sp MedJ 1989;37:124-6) 
Mulfiple endocrine neoplasia type 2A (MEN 2A) is an auto-somal dominant syndrome characterized by the associa-
tion of medullary thyroid carcinoma (MTC), pheochromocyto-
ma, and hyperparathyroidism. A carrier of the MEN 2A gene 
often shows clinical signs or symptoms of these associated dis-
eases, such as cervical nodes, hypertensive attacks, and re-
peated severe headaches in the third or fourth decade of life (I), 
However, in the kindred at high risk for MEN 2A, early diag-
nosis of MTC is possible even at an eariy stage, including "oc-
cult disease," by measuring plasma calcitonin (CT) concentra-
tions after intravenous injection of calcium or pentagastrin (2). 
tn recent years, prospective studies including children have been 
initiated in some insriturions, and many young parients with 
MEN 2A have been diagnosed and treated surgically (3-5). 
A Japanese family with MEN 2A was invesfigated regarding 
early diagnosis of MTC by screening tests in childhood and the 
possibility of DNA diagnosis of gene carriers. 
Patients and Methods 
The H-kindred is a Japanese family (cunently 87 members) 
with MEN 2A. Members of this family had many episodes of 
cervical tumors and often experienced characteristic attacks 
such as repeated headache, sweating, and pale face. Some un-
derwent thyroidectomies and/or adrenalectomies. However, 
most of the family members had been reluctant to consult physi-
cians because of the surgery required for relatives and the severe 
hypertensive attacks which were sometimes fatal. Patients were 
also anxious about violation of the individual privacy of un-
affected relatives. For these reasons, no systematic investigation 
had been performed on this family. The clinical complaints of 
cervical nodule and repeated severe headache in a 34-year-old 
male in this family in 1987 provided us the opportunity to ap-
proach this family. 
Screening program 
The medical history and cause of death of family members 
were investigated by interviewing their relatives or studying 
their medical records. The surviving pafients were interviewed 
and their medical records reviewed. 
Screening programs included biochemical measurements of 
specimens from the first- and second-degree relatives ofthe pa-
tients. For detection of MTC, plasma CT concentrations were 
measured following provocative agents. CT was determined by 
radioimmunoassay on blood samples coUected before and at 2, 
5, and 10 minutes following intravenous administration of pen-
tagastrin (0.5 p.g/kg/5 sec). For detection of pheochromocyto-
mas, 24-hour urine specimens were collected for an estimation 
of the excretion of epinephrine and norepinephrine. 
Genotype at RBP3 locus 
DNA was extracted from leukocytes or lymphobtastoid cell 
lines ofeach member of the family. Restriction fragment length 
polymorphisms (RFLPs) were determined using H.4IRBP, con-
taining the 3' region of the cDNA of refinol binding protein 3 (6) 
as a probe after complete digesfion of DNA with Bglll. 
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Fig 1—Pedigree ofthe H-kindred. A crossbar through the indi-
vidual symbol indicates the patient is deceased. MTC = 
medullary thyroid carcinoma, pheo = pheochromocytoma, 
SUSP = suspected MTC, .squares = males, circles = females. 
Results 
Eighteen patients with MEN 2A were confirmed by medical 
records or screening programs. This autosomal dominant syn-
drome is inherited with high penetrance (Fig 1), Screening tests 
are continued yearly until the age of 40 for the relatives whose 
data were negative for MEN 2A. 
Results of screening program 
Twenty-six family members (aged 3 to 62) were screened for 
the progression of C-cell abnormalities and pheochromocyto-
mas. Abnormal responses of CT levels were observed in six sub-
jects (aged 16, 19, 33, 35, 37, and 57) (Fig 2). Five underwent 
total thyroidectomy with regional lymph node dissection soon 
after the screening test, and in each case multicentric growth of 
MTC was found. The remaining patient, a 33-year-old male, 
was not operated on because of a less sharp response compared 
with that of the others, but he has been followed carefully. The 
two youngest parients, a 16-year-old boy and his 19-year-oId sis-
ter, underwent total thyroidectomy for bilateral MTC (the largest 
diameters; 16 mm and 3 mm in the boy; 14 mm and 7 mm in the 
giri). Small metastatic foci of MTC were found in the cervical 
lymph nodes of the t6-year-otd boy. The oldest pafient, a 57-
year-old femate, had huge bilateral MTC. Her stimulated 
plasma CT level was more than 200,000 pg/mL (the normal up-
per limit of plasma CT level in our series was 150 pg/mL). 
The 26 family members screened also had 24-hour urinary 
excretions of epinephrine and norepinephrine measured for de-
tection of pheochromocytoma. Three of these subjects (aged 35, 
37, and 57), who had been diagnosed as having MTC in the 
screening process, showed abnormal elevafions (Fig 3). Adrenal 
pheochromocytomas were detected upon further examination, 
and a right adrenalectomy, a left adrenalectomy, and a bilateral 
adrenalectomy were performed in the 35-year-oId, 37-year-old, 
and 57-year-otd patients, respectivety. 
Prediction of the gene carrier by RFLPs at the RBP3 locus 
Unfortunately, the RBP3 allele cosegregating with the dis-
ease could not be detennined from the data obtained, and there-
fore DNA diagnosis of gene carriers was not possible in this 
family using this particular probe. 
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Fig 2—Results of screening with the measurement of plasma 
calcitonin concentration following an intravenous injection of 
pentagastrin (0.5 \x.glkgl5 sec). 
Discussion 
Clinical screening programs for MEN 2A with stimulated 
plasma CT measurements have been utilized for early detection 
of MTC. The results of these screening programs have clarified 
the importance of early diagnosis of this hereditary malignant 
syndrome with the improvement of prognosis for affected pa-
tients (7). 
Pediatric implications for MEN 2A have been discussed since 
the establishment of the value of measuring plasma CT for early 
diagnosis of MTC which has resulted in the inifiation of periodic 
screening tests for young family members. Gagel et at (4) re-
ported the results of a prospective screening program for MEN 
2A in which periodic tests had been inifiated at the age of 5. In 
their series hatf of the gene carriers were found before the age of 
12, and in 80% of those patients the diagnosis of MEN 2A was 
made before the age of 20. Tetander et at (5) reported the results 
of totat thyroidectomy in 14 children with MEN 2A who were 12 
years old or younger and recommended initiating the screening 
test at the age of t year and performing total thyroidectomy as 
soon as MTC or C-cetl hyperplasia was diagnosed. In our series, 
two of the 11 members aged 19 or younger who received screen-
ing tests were diagnosed as having MEN 2A and were treated 
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Fig 3—Results of screening with the measurement of 24-hour 
urinary excretion of epinephrine and norepinephrine. Pheo-
chromocytoma was diagnosed in three members aged 35, 37, 
and 57. 
surgically. Surgery has shown MTC metastases to the cervical 
lymph nodes in a 16-year-otd mate. Therefore, despite the trou-
blesome procedures and the emotional strain burdening at-risk 
infants and children who have no clinical complaints, these 
screening programs must be started in childhood for improve-
ment of the prognosis in this syndrome. 
Recently the gene predisposing to MEN 2A was assigned to 
the pericentromeric region on chromosome 10 by the tight link-
age with the RBP3 gene (8,9), and this linkage was confirmed in 
a Japanese family (10). DNA diagnosis may be possible in an 
informative family by determining genotypes at the RBP3 locus 
if the allele cosegregating with the disease can be determined. In 
our family, howeven it has not been possible because the af-
fected parents were deceased or homozygous at the RBP3 locus 
with Bglll digestion. We are now trying other enzymes and 
other probes linked with MEN2A, and DNA diagnosis of gene 
carriers is expected to be possible in this family soon. 
The early detection of MEN 2A gene earners may prevent 
noncarriers of the MEN 2A gene from having periodic, trou-
blesome screening tests. DNA can be obtained from peripheral 
blood samples at the initial screening test, from the umbilical 
cord blood samples at birth, or theoretically even from amniotic 
fluid or chorionic villus samples obtained before birth (11). What 
screening procedure is best within MEN 2A families? Perhaps 
screening programs should inctude DNA linkage anatysis for 
detection of MEN 2A gene carriers in addition to the conven-
tional screening tests as more informative markers are obtained 
closer to and flanking the MEN 2A gene. 
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